Ellipsis has leveraged this core expertise in human disease research and genetic analysis to provide superior quality genotyping services to government, academic and industrial clientshttp://biz.yahoo.com/iw/061010/0170670.html
"This is another example of how Ellipsis enhances DNAPrint's diverse service capacity worldwide," stated Richard Gabriel, DNAPrint Genomics' President and CEO. "Dr. Rubin and his team are to be congratulated on their new product offerings, which we expect to become an established benchmark for genomic testing in the future."
Market Data 
Markets 
AI
